Clario neuroscience expertise
Our decades of experience and expertise across neuroscience diseases include:
- Dementias
- Movement disorders
- Mood and psychiatric disorders
- Multiple Sclerosis (MS)
- Pain management
- Headache disorders
- Seizure disorders
- And more…
Holistic solutions
Single sourced, holistic solutions under one roof regardless of study complexities or requirements.
Collaborative trial design
Collaborative charter and protocol development to build a successful trial from the start, including endpoint selection.
Support for every phase of your neuroscience journey
Your neuroscience development journey is unique, and we are here to support you every step of the way.
Our comprehensive, tailored services include Imaging Solutions, eCOA, Cardiac Safety, Respiratory Monitoring, Digital Body Movement Analysis, and more.
No matter the demands or complexity of your study, we provide the expertise and tools needed to achieve your research goals efficiently and effectively.
Discover how we helped a groundbreaking Alzheimer’s disease study earn accelerated FDA approval.
Extensive solutions, expert knowledge
Our comprehensive neuroscience trial solutions support your need to assess the efficacy, safety and patient quality of life quickly and accurately in clinical trials – through broad solutions including:
Imaging Solutions
Clario is a leader in centralized imaging services, providing sponsors with comprehensive support for clinical trials across all neuroscience indications globally. Advanced medical imaging provides precise information on the brain, informing patient eligibility, drug efficacy and patient safety. Clario uses validated and compliant image processing workflows, as well as the latest in Artificial Intelligence assisted analysis methods for evaluating investigational therapies.
Learn more
eCOA
Neuroscience trials often involve complex eCOA endpoints, demanding advanced rater training and meticulous data oversight. In addtion to our flexible eCOA solutions (including ePROs, eClinROs and ePerfOs), science-driven training for raters, participants, and caregivers reduces variability and enhances reliability. With our proactive approach to data monitoring, we ensure high quality by identifying potential issues early and recommending corrective actions.
Learn more
Cardiac Safety
Ensure patient safety with our advanced cardiac safety data collection technology. Our ECG, arrhythmia, and blood pressure solutions help you understand the safety profile of your drug from early through late phase studies. Our team of experts will work with you to strategize, collect, and analyze data, ensuring precise and reliable results for your clinical trials.
Learn more
Digital Movement Analysis
Enhance your neuroscience trial research with Clario’s Opal V2C® precision motion monitoring and actigraphy solution. This technology assesses mobility and functional impairments, providing objective high-quality data on gait, balance, and mobility. Our solution ensures accurate and immediate insights into these critical areas, improving the quality and effectiveness of your clinical trials.
Learn more
Respiratory
Ensure drug safety with Clario’s precise lung function testing. Our purpose-built devices and customized software integrate seamlessly with your protocol workflow, enabling collection of full, high-resolution spirometry curves and other PFT metrics.
Learn more
Clinical Adjudication
Leverage Clario’s clinical adjudication services to enhance the accuracy and credibility of trial results. Our medical experts specialize in assessing neuro-related events such as seizures, and major adverse cardiovascular events (MACE) like heart attacks and strokes, ensuring precise and reliable evaluations throughout our comprehensive event adjudication process.
Learn moreExtensive solutions, expert knowledge
Our comprehensive neuroscience trial solutions support your need to assess the efficacy, safety and patient quality of life quickly and accurately in clinical trials – through broad solutions including:
Imaging Solutions
Clario is a leader in centralized imaging services, providing sponsors with comprehensive support for clinical trials across all neuroscience indications globally. Advanced medical imaging provides precise information on the brain, informing patient eligibility, drug efficacy and patient safety. Clario uses validated and compliant image processing workflows, as well as the latest in Artificial Intelligence assisted analysis methods for evaluating investigational therapies.
eCOA
Neuroscience trials often involve complex eCOA endpoints, demanding advanced rater training and meticulous data oversight. In addtion to our flexible eCOA solutions (including ePROs, eClinROs and ePerfOs), science-driven training for raters, participants, and caregivers reduces variability and enhances reliability. With our proactive approach to data monitoring, we ensure high quality by identifying potential issues early and recommending corrective actions.
Cardiac Safety
Ensure patient safety with our advanced cardiac safety data collection technology. Our ECG, arrhythmia, and blood pressure solutions help you understand the safety profile of your drug from early through late phase studies. Our team of experts will work with you to strategize, collect, and analyze data, ensuring precise and reliable results for your clinical trials.
Digital Movement Analysis
Enhance your neuroscience trial research with Clario’s Opal V2C® precision motion monitoring and actigraphy solution. This technology assesses mobility and functional impairments, providing objective high-quality data on gait, balance, and mobility. Our solution ensures accurate and immediate insights into these critical areas, improving the quality and effectiveness of your clinical trials.
Respiratory
Ensure drug safety with Clario’s precise lung function testing. Our purpose-built devices and customized software integrate seamlessly with your protocol workflow, enabling collection of full, high-resolution spirometry curves and other PFT metrics.
Clinical Adjudication
Leverage Clario’s clinical adjudication services to enhance the accuracy and credibility of trial results. Our medical experts specialize in assessing neuro-related events such as seizures, and major adverse cardiovascular events (MACE) like heart attacks and strokes, ensuring precise and reliable evaluations throughout our comprehensive event adjudication process.
Focus areas
From neurodegenerative diseases to psychiatric conditions and more, our neuroscience expertise spans a diverse spectrum of disorders, including but not limited to:
Dementias
- Alzheimer’s disease
- Other dementias
Headache disorders
- Migraine
Movement disorders
- Parkinson’s Disease
- Ataxia
- Huntington’s Disease
Pain management
- Chronic pain
- Neuropathic pain
Psychiatric disorders
- Major depression
- Schizophrenia
- Attention Deficit Hyperactivity Disorder (ADHD)
- Mood and Anxiety disorders
Amyotrophic Lateral Sclerosis (ALS)
Epilepsy/seizures
Multiple Sclerosis
Meet the Clario neuroscience team
Clario’s team of dedicated neuroscience experts are consistently delivering thought leadership to advance endpoint collection technologies, data analysis methodologies, engage regulators to drive progress and support clinical trial success.
- Scientists
- Industry recognized KOLs
- Physicians
- Regulatory specialists
- Statisticians
- Solution and product designers
- Project managers
- Regulatory specialists
- Customer care
-
Todd Rudo, M.D.
Chief Medical Officer
-
Joyce Suhy, Ph.D.
EVP Medical Imaging and Specialty Solutions
-
Luc Bracoud, M.Sc.
Senior Director, Medical and Scientific Affairs
-
Wan Chi (Gigi) Lau
VP, Medical Imaging
-
David Scott, Ph.D.
VP, Medical & Scientific Affairs
-
Todd Lustine, M.D., M.S., FCCP
Vice President, Medical Science, Respiratory
-
Kristen Sowalsky, Ph.D., D.C.
VP, Medical & Scientific Affairs, Precision Motion
-
Fay Horak, Ph.D., PT
Chief Scientist
-
Prateek Verma, M.D.
Director, eCOA Science and Consulting
-
Laura Khurana, M.P.H.
Principal Scientific Advisor
-
Vickas Patel, M.D., Ph.D.
Vice President and Chief Medical Officer, Cardiology
-
Jeff Heilbraun, M.S.
Vice President, Medical and Scientific Affairs, Cardiology
-
Chris Conklin, Ph.D.
Senior Scientist, Neuroscience
-
Madhura Ingalhalikar, Ph.D.
Scientist, Neuroscience
-
Olivier Rousset, Ph.D.
Scientist, Neuroscience
Experience in neuroscience trials isn’t optional – it’s essential
Gain the benefits of decades of Clario’s neuroscience clinical trial expertise, designed to ensure your study’s success in measuring efficacy, safety, and quality of life from start to finish. With a focus on delivering exceptional results, we offer:
Protocol design
Leverage our experience to design a robust study for precise execution and accurate results, giving you confidence in your trial’s foundation.
Endpoint expertise
Benefit from our scientists’ guidance in selecting the best endpoint solutions, ensuring reliable, high-quality data that drives meaningful conclusions on efficacy, safety, and quality of life.
Site management
Enjoy seamless operations at every study location, regardless of scale or complexity, with our comprehensive site management support.
Patient support
Enhance the patient experience with our dedicated assistance, ensuring optimal data collection and fostering positive trial outcomes.
Related resources
Optimal Digital Endpoint Selections of Movement in Parkinson’s disease
Evaluating Participant Burden: Electronic Patient-Reported Outcome Assessment Completion Time in Clinical Trials for Parkinson’s Disease
Navigating the Future of Alzheimer’s Treatment
Simplifying ARIA-E Assessment with SSAE Scales
Hit your neuroscience trial milestones with confidence.
Contact us today to begin our partnership and enhance the speed, quality and efficiency of your neuroscience clinical trials.